Jin Long Chen
Directeur/Membre du Conseil chez TENAYA THERAPEUTICS, INC.
Fortune : 2 M $ au 30/04/2024
Postes actifs de Jin Long Chen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| TENAYA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/10/2016 | - |
| Independent Dir/Board Member | 01/10/2016 | - |
Historique de carrière de Jin Long Chen
Anciens postes connus de Jin Long Chen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| NGM BIOPHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/01/2008 | 04/04/2023 |
| Directeur Technique/Scientifique/R&D | 01/01/2008 | 04/04/2023 | |
| Fondateur | 20/12/2007 | 04/04/2023 | |
| President | 01/01/2008 | 01/11/2014 | |
| AMGEN INC. | Directeur Technique/Scientifique/R&D | 01/01/2004 | 01/01/2008 |
| Corporate Officer/Principal | - | 01/01/2008 | |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - | - |
Formation de Jin Long Chen
| Fu Jen Catholic University | Undergraduate Degree |
| National Taiwan University | Graduate Degree |
| University of California, Berkeley | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
| Taïwan | 3 |
Opérationnelle
| Director/Board Member | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| NGM BIOPHARMACEUTICALS, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| TENAYA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |
- Bourse
- Insiders
- Jin Long Chen
- Expérience
